1. Targeting High-Density Lipoproteins: Increasing De Novo Production Versus Decreasing Clearance

   • Arshag D. Mooradian
   • Michael J. Haas

   Current Opinion 21 April 2015 Pages: 713 - 722

   

2. Antisense Approach to Inflammatory Bowel Disease: Prospects and Challenges

   • Irene Marafini
   • Davide Di Fusco
   • Giovanni Monteleone

   Leading Article 25 April 2015 Pages: 723 - 730

   

3. Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status

   • Marc Peeters
   • Meinolf Karthaus
   • Jean-Yves Douillard

   Review Article Open access 21 April 2015 Pages: 731 - 748

   

4. Disease Modification in Epilepsy: From Animal Models to Clinical Applications

   • Melissa L. Barker-Haliski
   • Dan Friedman
   • H. Steve White

   Review Article 30 April 2015 Pages: 749 - 767

   

5. Ibrutinib: A Review of Its Use in Patients with Mantle Cell Lymphoma or Chronic Lymphocytic Leukaemia

   • Esther S. Kim
   • Sohita Dhillon

   Adis Drug Evaluation 24 March 2015 Pages: 769 - 776

   

6. Alogliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus

   • Gillian M. Keating

   Adis Drug Evaluation 09 April 2015 Pages: 777 - 796

7. Vorapaxar: A Review of Its Use in the Long-Term Secondary Prevention of Atherothrombotic Events

   • James E. Frampton

   Adis Drug Evaluation 21 April 2015 Pages: 797 - 808

8. Tiotropium Respimat^®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β₂-Adrenergic Agonists

   • Kate McKeage

   Adis Drug Evaluation 21 April 2015 Pages: 809 - 816

   

9. Isavuconazonium: First Global Approval

   • Paul L. McCormack

   R&D Insight Report 23 April 2015 Pages: 817 - 822